Our finding that OMAB, L11.3, and, IgM auto-antibodies from eight plasma samples showed a very high selectivity towards Aβ oligomers suggests that human IgM auto-antibodies may confer a protective effect in vivo, both normally and when used for AD passive immune therapy. The gene discussed is CD40LG; the disease is Alzheimer disease.